The Oncology Institute, Inc. (TOI)
USD 0.19
(-2.0%)
USD 0.19
(-2.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 86.32 Million USD | -8.33% |
| 2022 | 94.16 Million USD | 182.52% |
| 2021 | -114.11 Million USD | -2023.91% |
| 2020 | 5.93 Million USD | 342.48% |
| 2019 | -2.44 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 84.58 Million USD | 0.96% |
| 2024 Q1 | 83.78 Million USD | -2.95% |
| 2023 Q1 | 94.78 Million USD | 0.65% |
| 2023 Q3 | 89.81 Million USD | 2.71% |
| 2023 FY | 86.32 Million USD | -8.33% |
| 2023 Q2 | 87.44 Million USD | -7.74% |
| 2023 Q4 | 86.32 Million USD | -3.88% |
| 2022 Q4 | 94.16 Million USD | 110.98% |
| 2022 FY | 94.16 Million USD | 182.52% |
| 2022 Q3 | 44.63 Million USD | 198.95% |
| 2022 Q2 | -45.1 Million USD | 40.63% |
| 2022 Q1 | -75.97 Million USD | 33.42% |
| 2021 FY | -114.11 Million USD | -2023.91% |
| 2021 Q1 | 13.92 Million USD | 134.83% |
| 2021 Q3 | 4.69 Million USD | 145.58% |
| 2021 Q2 | -10.29 Million USD | -173.88% |
| 2021 Q4 | -114.11 Million USD | -2532.96% |
| 2020 FY | 5.93 Million USD | 342.48% |
| 2020 Q4 | 5.93 Million USD | 694.0% |
| 2020 Q3 | -998.57 Thousand USD | 9.48% |
| 2020 Q2 | -1.1 Million USD | -145.09% |
| 2020 Q1 | 2.44 Million USD | 0.0% |
| 2019 FY | -2.44 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 1.41 Billion USD | 93.88% |
| Addus HomeCare Corporation | 110.39 Million USD | 21.799% |
| AirSculpt Technologies, Inc. | 89.4 Million USD | 3.444% |
| Amedisys, Inc. | 341.35 Million USD | 74.71% |
| American Oncology Network, Inc. | 99.78 Million USD | 13.488% |
| Astrana Health, Inc. | 27.2 Million USD | -217.297% |
| Aveanna Healthcare Holdings Inc. | 1.45 Billion USD | 94.068% |
| IMAC Holdings, Inc. | -221.51 Thousand USD | 39071.88% |
| biote Corp. | 25.86 Million USD | -233.708% |
| Cryo-Cell International, Inc. | 10.48 Million USD | -722.949% |
| Cross Country Healthcare, Inc. | -11.82 Million USD | 829.915% |
| COMPASS Pathways plc | -187.58 Million USD | 146.019% |
| DocGo Inc. | -12.78 Million USD | 775.01% |
| The Ensign Group, Inc. | 1.36 Billion USD | 93.66% |
| Healthcare Services Group, Inc. | -10.69 Million USD | 907.172% |
| InnovAge Holding Corp. | 56.08 Million USD | -53.911% |
| Assure Holdings Corp. | 14.68 Million USD | -487.978% |
| The Joint Corp. | -2.47 Million USD | 3581.686% |
| LifeStance Health Group, Inc. | 432.21 Million USD | 80.027% |
| Mobile-health Network Solutions Class A Ordinary Shares | -6.05 Million USD | 1526.76% |
| ModivCare Inc. | 1.13 Billion USD | 92.409% |
| NewGenIvf Group Limited | 278.44 Thousand USD | -30902.805% |
| Novo Integrated Sciences, Inc. | 4.05 Million USD | -2028.731% |
| Option Care Health, Inc. | 822.56 Million USD | 89.505% |
| P3 Health Partners Inc. | 83.7 Million USD | -3.13% |
| P3 Health Partners Inc. | 83.7 Million USD | -3.13% |
| The Pennant Group, Inc. | 323.57 Million USD | 73.321% |
| Surgery Partners, Inc. | 2.86 Billion USD | 96.988% |
| Syra Health Corp. Class A Common Stock | -3.03 Million USD | 2947.223% |
| Talkspace, Inc. | -123.9 Million USD | 169.67% |
| Talkspace, Inc. | -123.9 Million USD | 169.67% |
| The Oncology Institute, Inc. | 86.32 Million USD | 0.0% |